(31-5%) were correctly described as inflammatory or non-inflammatory and in five (2-5%) no diagnosis could be made. Only in seven cases (3.5%) was an inaccurate (false positive) cytological diagnosis made.
There are many published descriptions of the microscopic analysis of synovial fluid from normal and diseased joints. Various cell types have been identified in synovial fluid, including neutrophils, lymphocytes, immunoblasts,5 ragocytes,6 eosinophils,7 and LE cells8 together with a diversity of crystals.' Surveys have suggested that despite the potential of synovial fluid microscopic analysis it is rarely undertaken and when attempted is often done in a way that limits the potential information of the technique. In the section of osteoarticular pathology of the university department of rheumatology we have routinely analysed specimens of synovial fluid for 14 years, and our experience from between 8000 and 8500 analyses has suggested that synovial fluid microanalysis is potentially a more useful diagnostic investigation than has been previously recorded.
In this study we analysed synovial fluids from 1892 patients, from whom clinical follow up of more than three years was available, using techniques which could be routinely used in any pathology laboratory. From these data we derived a scheme for the analysis of any synovial specimen. We Briefly, these criteria are: rheumatoid disease-as defined by the revised American Rheumatism Association (ARA) criteria9; systemic lupus erythematosus-at least four ARA criteria'0; septic arthritis-culture of organism from synovial fluid or synovium, or both; gout-presence of sodium urate crystals in joint; calcium pyrophosphate deposition disease-monoarthropathy in which the synovial fluid contained an average of more than one intracellular calcium pyrophosphate crystal per 50 x oil immersion objective field area in a routine unstained preparation (see below); internal derangement-meniscal or cruciate ligament tear associated with recurrent or continuous joint swelling for more than three months proved arthroscopically; reactive arthritis-development of oligoarthropathy in association with gastrointestinal or urinary tract infection but with no demonstrable organism in the joint; ankylosing spondylitis-radiological or clinical evidence, or both, of sacroiliitis or spinal ankylosis, or both, in HLA-B27 positive patients; Reiter's syndrome-only patients with the triad of non-specific urethritis, arthritis, and conjunctivitis were included in this group; psoriatic arthritis-established typical psoriatic skin lesions and an associated seronegative oligoarthropathy or polyarthropathy; monoarticular osteoarthritis-radiological evidence of joint space narrowing with at least one of the following: subarticular bone sclerosis, cyst formation, or osteophytes, together with no history of previous inflammatory arthritis; arthropathy associated with inflammatory bowel diseaseseronegative arthritis in a patient with large bowel Crohn's disease or ulcerative colitis proved by biopsy.
Joints were aspirated between two days and nine weeks from the onset of local symptoms and signs. Of necessity patients in different disease groups were not matched for age, sex, or treatment, and because of the diversity of disease groups and the size of the study no attempt was made to subclassify the arthritis further by patients' symptoms or signs.
Microscopy
Synovial fluid samples received in 2 Data analysis and production of algorithm The data for cell and crystal distribution were analysed to identify criteria specific for the different arthropathies and for groups of disorders. From these an analytical scheme (algorithm) was designed which could be applied to the examination of all synovial fluids.
ASSESSMENT OF THE ANALYTICAL SCHEME Two hundred sequential synovial fluids from patients with established clinical diagnoses were sent to the laboratory in lithium heparin bottles as before, but the only clinical data made available were the patient's name, sex, age, and hospital number. The fluids were processed as before, and after microscopic examination the data derived were processed through the algorithm. On the basis of this each patient was assigned a cytological diagnosis which fell into one of the five following groups: (a) no diagnosis possible; (b) either an inflammatory or a non-inflammatory arthropathy; (c) one of a short list of differential diagnoses; (d) a short list of differential diagnoses with single favoured diagnosis; (e) an exact diagnosis.
At the end of the study the clinical and cytological diagnoses were compared and the accuracy of cytological diagnosis assessed.
Results

ANALYSIS OF CRYSTALS, TISSUE FRAGMENTS, AND ORGANISMS
Crystals of sodium urate were only ever found in inflammatory arthropathies and were taken as being diagnostic of gout.
Crystals of hydroxyapatite were found only in osteoarthritis (328 of the 433 cases (76%)) and rheumatoid arthritis (82 of the 633 cases (13%)). Crystals of calcium pyrophosphate were seen in synovial fluids with cell counts >lI5 x 109/l (inflammatory type-see below), a pattern consistent with pseudogout, but were also seen (in much smaller quantities) in non-inflammatorytype fluids (<1 x109 cells/l). This was interpreted as being from joints with a noninflammatory arthropathy and coincidental chondrocalcinosis.
In every case of septic arthritis that fulfilled the diagnostic criteria used in this study organisms were identified microscopically in the fluid.
Fragments of fibrocartilage were seen in cases of longstanding internal derangement and cartilage in patients with osteoarthritis.
SYNOVIAL FLUID CYTOANALYSIS
The following cell types were clearly differentiated in cytocentrifuge/wet preparations using simple morphology. As some can be considered morphological variants of others certain cell types have been grouped together. The disease distribution of all these cells has been analysed Figure 2 Algorithmfor the analysis ofobservations derivedfrom synovialfluid microscopy. DB=Dohle's body cells; CPM=cytophagocytic monocytes; LMC=large mononuckar cells. We believe this is the first study of this type to be reported, in which quantitative and qualitative synovial fluid microscopic data from patients with so many diseases have been compared and a straightforward analytical scheme proposed and tested.
Because of the patient selection criteria used in this study we have no doubt that a closer correlation of clinical and cytological data for patients in each group will lead to refinements of the algorithm that may have diagnostic or prognostic implications, or both. Nevertheless, because it is applicable to any patient with a joint effusion, could be undertaken currently in any hospital with a basic pathology service, and because results can be made available within two to three hours of aspiration we feel that even as it stands this method of assessing synovial fluid represents a useful basic screening test. We have used it for some time and find it valuable in rheumatological practice, particularly in assessing patients with oligo-and monoarthropathies. Discussion with our colleagues in other hospital specialties (general medicine, orthopaedics, geriatrics, etc) and general practitioners, all of whom are using the service increasingly frequently, has shown that they too feel this has positively altered patient management, offering particular advantages in diagnosis, for following up patients with joint disease, and in rationalising specialist referral policy. This 
